Gold

Gold
Gold

Intel stock continues to surge after extended Google partnership

Shares of Intel extended gains for a seventh consecutive session on Thursday after the chipmaker announced an expanded collaboration with Google to develop next-generation processors for artificial intelligence data centers. The stock rose about 3% in morning trading, building on a powerful rally that has seen shares climb 47.5% over the current seven-session streak. If

Read More
Gold

Why Tesla stock is down 1% despite reports of a new EV

Tesla shares attempted another rebound on Thursday but failed to sustain momentum, slipping about 1% after opening higher. The initial gains followed reports that the company is considering a new electric vehicle. However, the reaction faded quickly, reflecting continued investor caution. New EV plans fail to excite investors Tesla is exploring an all-new electric vehicle,

Read More
Gold

US ETF AUM to surpass $25 trillion by 2030, says Citigroup

Citigroup has raised its growth outlook for the US ETF market, projecting that assets under management could surpass $25 trillion by 2030, up sharply from current levels of $10.4 trillion as of March 2025. The forecast highlights strong inflow momentum and increasing investor preference for cost-efficient investment vehicles. The upward revision reflects growing investor preference

Read More
Gold

UnitedHealth, US insurer stocks surge on Tuesday: here’s why

Shares of major US health insurers jumped in premarket trading on Tuesday following the government’s announcement of a larger-than-expected increase in 2027 payment rates for Medicare Advantage plans.  Insurance giant UnitedHealth led the rally, climbing 6.9%, while CVS Health, Elevance Health, Centene , and Molina Healthcare rose between 3.6% and 6%. Notably, Humana surged 10.7%,

Read More
Gold

Goldman Sachs flags Big Tech buy as Iran war dents valuations

Big Tech stocks, which have come under sustained pressure in recent months, may be entering a more attractive phase for investors as valuations reset and geopolitical tensions reshape market dynamics, according to analysts at Goldman Sachs. The sector’s sharp pullback, exacerbated by the ongoing Iran conflict, has led to a reassessment of growth expectations and

Read More
Gold

Dow Jones slip 200 points as Trump Iran deadline fuels market fears

Wall Street’s main indexes opened lower on Tuesday as investors assessed escalating tensions between the United States and Iran ahead of President Donald Trump’s deadline for Tehran to reopen the Strait of Hormuz. The Dow Jones Industrial Average was down 214 points, or 0.46%, while the S&P 500 index fell 0.42% and the Nasdaq 100

Read More
Gold

ECB must hike rates in April to anchor inflation expectations: Commerzbank

Faced with the twin challenges of rising inflation and slowing growth driven by the oil price shock, the European Central Bank is under pressure to act, with Commerzbank AG anticipating the ECB to prioritise long-term inflation expectations and consider an interest rate hike as early as its next meeting at the end of April. While

Read More
Gold

Zcash extends gains as the broader crypto market underperforms

The cryptocurrency market has been bearish over the past 24 hours, with Bitcoin and Ether currently in the red. Bitcoin hit the $70,000 mark on Monday but is now down 1.4% and is trading around $68,400. Ether also risks dropping below $2,000 if the selloff persists. However, ZEC, the native coin of the Zcash ecosystem,

Read More
Gold

Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?

Novo Nordisk announced on Tuesday that it is making a higher-dose version of its popular weight-loss medication, Wegovy, available across the United States.  The new 7.2-milligram dose, branded as Wegovy HD, was recently approved under the FDA Commissioner’s National Priority Review Voucher program last month, marking a significant development in obesity treatment options. Before this

Read More
Gold

How healthcare became the most reliable source of paychecks in the US

The American labour market has long been a complex machine of shifting gears, but in the current economic landscape, one cylinder is firing with more reliability than all others combined. While technology and manufacturing navigate the choppy waters of replacement by AI and perils brought on by tariffs, the healthcare sector has emerged as a

Read More